Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation

A method for treating a patient for a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of administering a nutraceutical and phytochemical composition to the patient, said nutraceutical portion of the composition consisting of vitamin C, vitamin E, and zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms and appropriate nutraceutical and phytochemical components for preventing or reducing viral and bacterial infections and inflammations, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include five or more of the following anti-infectious phytochemicals:

• fulvic acid;
• echinacea purpura extract, sage extract uncaria tomentosa extract Black Elderberry extract or American Elderberry extract;
• pomegranate extract;
• and Radix bupleuri extract
• two or more of the following anti-inflammatory nutraceuticals:
• Omega-3 fatty acids;
• eicosapentanoic acid (EPA) and docosahexanoic acid (DHA};
• Alpha-lipoic acid;
• five or more of the following anti-inflammatory phytochemicals
• Curcumin extract with piperine;
• green tea extract Boswellia serrata extract, containing three-acetyl-11-keto-beta-boswellic acid(—AKBA);
• resveratrol;
• Commiphora myrrha extract uncaria tomentosa extract extract of maritime pine bark;
• green tea extract Cannabidiol,
• wherein, the step of administering a nutraceutical composition to the patient containing zinc with the cofactor of methionine,
• wherein the step of administering the nutraceutical composition to the patient in the effective amount of vitamin C is 1000 mg;
• effective amount of vitamin E is 200 mg;
• and the effective amount of zinc is 25 mg,
• wherein the step of administering the effective amount of anti-infectious nutraceuticals in the composition include five or more of the following anti-infectious phytochemicals:
• a) 1000 mg fulvic acid extract
• b) 800 mg Echinacea purpura
• c) 800 mg Sage extract
• d) 400 mg Cat's Claw extract, namely Unicaria toments
• e) 200 mg Black Elderberry extract, namely Sambucus nigra or 200 mg American Elderberry extract, namely Sambucus canadensis
• f) 400 mg pomegranate extract and
• g) 400 mg Radix bupleuri extract and
• wherein the step of administering the effective amount of anti-inflammatory phytochemicals and nutraceuticals include:
• the following two anti-inflammatory nutraceuticals:
• 1000 mg Omega-3 fatty acids, total from eicosapentanoic acid (EPA) and docosahexanoic acid (DHA);
• and 200 mg Alpa-lipoic acid;
• and five or more of the following anti-inflammatory phytochemicals:
• 400 mg curcumin extract with piperine;
• 300 mg Green Tea extract;
• 800 mg of Boswellia serrata, containing its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA);
• 200 mg Resveratrol;
• 150 mg extract of Maritime pine bark extract;
• 400 mg Commiphora myrrha extract;
• and
• 400 mg uncaria tomentosa extract;
• and
• 50 mg cannabidiol (CBD).